Memphasys Ltd News

Memphasys Ltd: Notification of cessation of securities - MEM

Jul 31 18:45 ET

Memphasys Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 30 18:17 ET

Memphasys Ltd: $1M secured from major shareholder and R&D Tax Rebate loan

Jul 28 18:25 ET

Memphasys Ltd: Felix sales clinical trial and Oxidative Stress devel update

Jul 23 18:13 ET

Memphasys Ltd: Animal activity update - oxidative stress measurement system

Jul 18 20:42 ET

Memphasys Ltd: Details of Company Address

Jun 6 02:24 ET

Memphasys Ltd: Dr David Ali appointed full-time Chief Executive Officer

Jun 5 18:37 ET

Memphasys Ltd: s708 cleansing statement

Jun 2 20:33 ET

Memphasys Ltd: Notification regarding unquoted securities - MEM

Jun 2 20:25 ET

Memphasys Ltd: Application for quotation of securities - MEM

Jun 2 20:19 ET

Memphasys Ltd: Notification regarding unquoted securities - MEM

Jun 2 20:06 ET

Memphasys Ltd: Industry experts to expedite animal breeding products

May 29 18:20 ET

Memphasys Ltd: Investor Presentation

May 21 02:32 ET

Memphasys Ltd: Felix Japanese trial provides sperm preparation benefits

May 19 20:13 ET

Memphasys Ltd: Investor webinar invitation

May 19 18:27 ET

Memphasys Ltd: 2024 Investor Presentation

May 9 01:18 ET

Memphasys Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 29 01:46 ET

Memphasys Ltd: EGM update and advance of funds

Mar 17 19:48 ET

Memphasys Ltd: Felix TM System Sales Orders Accelerate in Japan

Mar 17 17:26 ET

Memphasys Ltd: Initial Director's Interest Notice MA

Mar 13 17:22 ET